scispace - formally typeset
K

Karin Thevissen

Researcher at Katholieke Universiteit Leuven

Publications -  173
Citations -  13665

Karin Thevissen is an academic researcher from Katholieke Universiteit Leuven. The author has contributed to research in topics: Candida albicans & Plant defensin. The author has an hindex of 49, co-authored 168 publications receiving 11610 citations. Previous affiliations of Karin Thevissen include Catholic University of Leuven.

Papers
More filters
Journal ArticleDOI

Mining the genome of Arabidopsis thaliana as a basis for the identification of novel bioactive peptides involved in oxidative stress tolerance

TL;DR: The identification and characterization of OSIP108 confirms the validity of the high-throughput approach, based on tiling array analysis in A. thaliana and functional screening in yeast, to identify bioactive peptides.
Journal ArticleDOI

Antifungal plant defensins: increased insight in their mode of action as a basis for their use to combat fungal infections.

TL;DR: This review focuses on the structure, biological activity and antifungal mode of action of some well-characterized plant defensins, with particular attention to their fungal membrane target(s), their induced cell death mechanisms as well as their antibiofilm activity.
Journal ArticleDOI

Artemisinins, New Miconazole Potentiators Resulting in Increased Activity against Candida albicans Biofilms

TL;DR: In this paper, the authors identify compounds that increase the activity of miconazole against Candida albicans biofilms and demonstrate that combining miconaxole and artesunate improves the antibiofilm activity.
Journal ArticleDOI

Antifungal activity of synthetic peptides derived from Impatiens balsamina antimicrobial peptides Ib-AMP1 and Ib-AMP4

TL;DR: It is shown that the all-D variants of Ib-AMP are as active on yeast and fungal strains as native peptides and could be improved by more than two-fold via replacement of amino acid residues by arginine or tryptophan, demonstrating the potential of the native Ib-AMPs to combat fungal infections.